Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Getinge ( ($SE:GETI.B) ) just unveiled an update.
Getinge has announced its Q2 Report 2025 will be released on July 18, 2025, followed by a conference call hosted by the company’s President & CEO and CFO. This event invites fund managers, analysts, and media to participate, potentially impacting stakeholders by providing insights into the company’s financial performance and strategic direction.
The most recent analyst rating on ($SE:GETI.B) stock is a Sell with a SEK190.00 price target. To see the full list of analyst forecasts on Getinge stock, see the SE:GETI.B Stock Forecast page.
More about Getinge
Getinge is a company that provides hospitals and life science institutions with products and solutions aimed at improving clinical results and optimizing workflows. Their offerings include products for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing, and life science. Getinge employs approximately 12,000 people worldwide and sells its products in 135 countries.
Average Trading Volume: 868,341
Current Market Cap: SEK53.02B
Find detailed analytics on GETI.B stock on TipRanks’ Stock Analysis page.